You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 7, 2024

METHYLDOPA AND HYDROCHLOROTHIAZIDE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Methyldopa And Hydrochlorothiazide patents expire, and when can generic versions of Methyldopa And Hydrochlorothiazide launch?

Methyldopa And Hydrochlorothiazide is a drug marketed by Chartwell Rx, Dava Pharms Inc, Ivax Sub Teva Pharms, Parke Davis, Purepac Pharm, Rising, Sandoz, Strides Pharma, Teva, and Watson Labs. and is included in forty-three NDAs.

The generic ingredient in METHYLDOPA AND HYDROCHLOROTHIAZIDE is hydrochlorothiazide; methyldopa. There are thirty-two drug master file entries for this compound. Additional details are available on the hydrochlorothiazide; methyldopa profile page.

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for METHYLDOPA AND HYDROCHLOROTHIAZIDE?
  • What are the global sales for METHYLDOPA AND HYDROCHLOROTHIAZIDE?
  • What is Average Wholesale Price for METHYLDOPA AND HYDROCHLOROTHIAZIDE?
Summary for METHYLDOPA AND HYDROCHLOROTHIAZIDE
Drug patent expirations by year for METHYLDOPA AND HYDROCHLOROTHIAZIDE

US Patents and Regulatory Information for METHYLDOPA AND HYDROCHLOROTHIAZIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Watson Labs METHYLDOPA AND HYDROCHLOROTHIAZIDE hydrochlorothiazide; methyldopa TABLET;ORAL 071922-001 Aug 29, 1988 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Teva METHYLDOPA AND HYDROCHLOROTHIAZIDE hydrochlorothiazide; methyldopa TABLET;ORAL 071822-001 Apr 8, 1988 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Strides Pharma METHYLDOPA AND HYDROCHLOROTHIAZIDE hydrochlorothiazide; methyldopa TABLET;ORAL 070614-001 Feb 2, 1987 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Watson Labs METHYLDOPA AND HYDROCHLOROTHIAZIDE hydrochlorothiazide; methyldopa TABLET;ORAL 070365-001 Mar 19, 1986 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Teva METHYLDOPA AND HYDROCHLOROTHIAZIDE hydrochlorothiazide; methyldopa TABLET;ORAL 071819-001 Apr 8, 1988 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Chartwell Rx METHYLDOPA AND HYDROCHLOROTHIAZIDE hydrochlorothiazide; methyldopa TABLET;ORAL 070182-001 Jan 15, 1986 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.